Amyloid Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Amyloid stocks.

Amyloid Stocks Recent News

Date Stock Title
Nov 7 LLY Eli Lilly snaps six straight sessions of losses
Nov 7 IONS Ionis' Q3 Earnings and Revenues Beat Estimates, New Launches in Focus
Nov 7 NTLA Intellia Therapeutics, Inc. (NTLA) Q3 2024 Earnings Call Transcript
Nov 7 LLY Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call
Nov 7 IONS A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
Nov 7 LLY What Makes Eli Lilly & Co (LLY) a Prospective Investment?
Nov 7 LLY Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
Nov 7 IONS Company News for Nov 7, 2024
Nov 7 NTLA Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Tops Revenue Estimates
Nov 7 ANVS Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
Nov 7 NTLA Intellia Therapeutics GAAP EPS of -$1.34 beats by $0.05, revenue of $9.11M beats by $1.25M
Nov 7 NTLA Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
Nov 7 IONS Ionis announces design for Phase III trial of Angelman syndrome therapy
Nov 7 LLY Is Eli Lilly And Co. (LLY) a Good Stock to Buy Now According to Redditors?
Nov 7 IONS Q3 2024 Ionis Pharmaceuticals Inc Earnings Call
Nov 7 GMAB Genmab AS (GMAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Pipeline ...
Nov 7 IONS Ionis Pharmaceuticals Inc (IONS) Q3 2024 Earnings Call Highlights: Navigating Revenue ...
Nov 7 ABUS Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: Promising Clinical Trials and ...
Nov 7 ABUS Q3 2024 Arbutus Biopharma Corp Earnings Call
Nov 6 LLY Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?
Amyloid

Amyloids are aggregates of proteins characterised by a fibrillar morphology of 7–13 nm in diameter, a β-sheet secondary structure (known as cross-β) and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits in plaques around cells which can disrupt the healthy function of tissues and organs.
Such amyloids have been associated with (but not necessarily as the cause of) more than 50 human diseases, known as amyloidosis, and may play a role in some neurodegenerative disorders. Some of these diseases are mainly sporadic and only a few cases are familial. Others are only familial. Some are iatrogenic as they result from medical treatment. One amyloid protein is infectious and is called prion in which the infectious form can act as a template to convert other non-infectious proteins into infectious form. Amyloids may also have normal biological functions; for example, in the formation of fimbriae in some genera of bacteria, transmission of epigenetic traits in fungi, as well as pigment deposition and hormone release in humans.Amyloids have been known to arise from many different proteins. These polypeptide chains generally form β-sheet structures that aggregate into long fibers; however, identical polypeptides can fold into multiple distinct amyloid conformations. The diversity of the conformations may have led to different forms of the prion diseases.

Browse All Tags